Acquisition Momentum Ourvita group’s recent acquisition of HBI and expansion moves indicate a growing CDMO platform with appetite for scale. This presents cross-sell opportunities to onboard current clients of HBI into Ourvita’s broader capabilities, including European presence and additional product categories.

Nutra Innovation Vitafoods Europe 2026 announcements around hydration, longevity, and gut health concepts signal a push into trend-forward nutraceuticals. Opportunities exist to position ourvita as the preferred CDMO for brands seeking innovative effervescent formats and ready-to-market products.

Certifications Value NSF/GMP, Sport certifications, Health Canada, Organic, Non-GMO, Kosher, and Halal capabilities highlight a strong compliance portfolio. This can be leveraged to win brands targeting stringent regulatory markets and premium segments, reducing time-to-market.

Turnkey Advantage Full-service development to commercialization with in-house analytical testing and QA focus. Pitch to mid-market brands seeking fast, reliable launch support, especially those needing stick packs and effervescent formats with shelf-ready delivery.

Regional Growth European expansion through the Laboratoria Natury acquisition enhances footprint and supply chain resilience. Use this to approach multinational brands aiming to regionalize manufacturing, diversify risk, and shorten lead times for European channels.